The FDA approved Kerendia in July 2021 for adults with chronic kidney disease associated with Type 2 diabetes to reduce the ...

VPDs with very short coupling intervals developing during an acute stage of myocardial infarction would predict the development of early cycled reentry, potentially culminating in VF, and requires ...

AtaCor Medical, Inc., a privately-held medical device company focused on transforming cardiac rhythm management, announced ...

Cytokinetics (CYTK) announced five presentations related to aficamten, an investigational cardiac myosin inhibitor, and hypertrophic ...

Abstract Rare and common genetic variants contribute to the risk of atrial fibrillation (AF). Although ion channels were among the first AF candidate genes identified, rare loss-of-function variants ...

Data show people with pulmonary arterial hypertension tend to stay in the hospital longer and have higher medical bills.

Hypertrophic cardiomyopathy, also known as HCM or thick heart syndrome, is a genetic condition that causes your heart muscle to thicken, affecting 1 in 200 people across the world. According to ...

Atrial functional mitral regurgitation (AFMR) is a common type of MR linked to high rates of heart failure, highlighting the ...

Tricuspid regurgitation (TR) severity is associated with poor prognosis in patients with atrial fibrillation (AF). Recently, right ventricular–pulmonary arterial (RV‐PA) coupling has been shown to be ...

that originates from one of the ventricles in the heart. The condition can lead to ventricular fibrillation and, therefore, sudden cardiac death.

Left untreated, ventricular tachycardia can trigger a medical emergency known as ventricular fibrillation (V-fib). With V-fib, the heart will not only beat rapidly but also beat erratically. Even with ...